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Without medical interventions, the risk of an HIV-positive 
mother transmitting the virus to her infant in utero, dur-
ing delivery or through breastfeeding ranges from 25% to 
48%.
4
 Most peripartum transmissions occur late in preg-
nancy and during labour; roughly half in the days prior to 
delivery and 30% during active labour.
5,6
 Advanced mater-
nal HIV disease (low CD4 cell count and high serum HIV 
viral load), HIV virus in genital fluid close to the time of 
birth, male sex of the infant and some types of genetically 
mediated immune responses in both mothers and children 
are all associated with increased risk of vertical transmis-
sion.
7
After delivery, the risk of transmission further increases 
with breastfeeding, which is responsible for up to 40% 
of all infant infections.
6
 There has been considerable de-
bate about the safest and most appropriate infant feeding 
method to promote HIV-free survival. In settings where re-
placement feeding does not meet the World Health Organi-
zation (WHO)’s AFASS (affordable, feasible, accessible, safe 
and sustainable) criteria, exclusive breastfeeding is recom-
mended for the first 6 months of life. Infants exposed to 
mixed feeding (breastmilk in combination with formula or 
other solids) face a considerably higher risk of HIV acquisi-
tion than those who receive only breastmilk; transmission 
risk is as much as 11 times greater among mixed-fed in-
fants.
8
Antiretroviral (ARV) medications for preventing mother-
to-child transmission (PMTCT) can dramatically reduce the 
likelihood of an infant becoming infected with HIV dur-
ing gestation and delivery. With the introduction of highly 
active antiretroviral (HAART) regimens during pregnancy 
and labour, vertical transmission of HIV has been largely 
eliminated in resource-rich settings such as the USA and 
Western Europe.
9
 However, MTCT of HIV remains the pre-
dominant source of infection in children in resource-lim-
ited countries, particularly in sub-Saharan Africa, where 
this mode of transmission accounts for 90% of paediatric 
infections and up to 15% of new HIV infections worldwide 
each year.
1
For resource-limited settings that lack the capacity to 
provide HAART to either all pregnant women or wom-
en who meet criteria to begin ARV treatment, the WHO 
recommends less complex PMTCT regimens.
10
 A single dose 
of nevirapine (NVP) to the mother at the onset of labour, 
and a dose of NVP to the baby after delivery, can reduce 
transmission rates to 13% at 14 - 16 weeks.
11
 Zidovudine 
(ZDV) from 28 weeks’ gestation, with a single dose of NVP 
to the mother at delivery and ZDV and NVP to the infant 




The efficacy of PMTCT programmes depends on the capac-
ity of the health care system to deliver services, and the 
willingness of women to accept HIV testing and their abil-
ity to follow through with PMTCT interventions. Essential 
elements of PMTCT programmes include testing all preg-
nant women for HIV, CD4 tests to identify those eligible for 
HAART, and ensuring that all women have the necessary 
drugs for PMTCT, including those who deliver at home. After 
delivery, PMTCT services must include sustained education 
and support for safer infant feeding options, co-trimoxa-
zole prophylaxis for HIV-positive or exposed newborns, HIV 
testing for infants, family planning, counselling, and refer-
rals to HIV care and treatment programmes. PMTCT efforts 
that effectively engage women during pregnancy offer op-
portunities to help mothers to protect their infants from 
HIV infection and can provide the health- and life-sustain-
ENHANCING PMTCT PROGRAMmeS 
THROUGH PSYCHOSOCIAL SUPPORT 
AND EMPOWERMENT OF WOMEN: THE 
mothers2mothers MODEL OF CARE
PMtCt InteRVentIons
shoRt RePoRt
Chloe A Teasdale, MPH
Mitchell J Besser, MD
mothers2mothers, Cape Town
In 2006, more than half a million children were newly infected with HIV, most from mother-to-child transmission (MTCT) 
in resource-limited countries.
1
 The global figures are staggering: every day, 1 400 children under the age of 15 die from 
AIDS-related illnesses.
2
 Of the 2.3 million children currently infected with HIV, most will die without treatment within 
the first 5 years of life – more than half before the age of 2.
3
 Even children not infected with HIV are affected by the 
epidemic: 15 million children have lost one or both parents to AIDS, and these children are more likely to experience 
poverty, homelessness and early death.
1
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ing care for mothers that is critical for their own survival 
and their children’s wellbeing.
Despite efforts to increase access to even the simplest ARV 
regimens, there are significant barriers in resource-limited 
settings to implementing effective public health PMTCT 
programmes. In low- and middle-income countries, less 
than 10% of women needing PMTCT services received them 
in 2006.
1
 While coverage is improving as national govern-
ments in many countries strive to implement PMTCT pro-
grammes, these continue to face obstacles from inadequate 
health care infrastructure including weak linkages between 
PMTCT services and HIV treatment programmes, overex-
tended staff in health facilities, and lack of stock of HIV test 
kits and ARVs. Along with health system challenges, there 
are significant social barriers (including stigma) that pre-
vent women from accepting HIV testing and treatment, as 
well as the common practice of mixed infant feeding which 
contributes to poorer outcomes for babies.
Nurses and lay counsellors in understaffed and overbur-
dened health care facilities often lack the time, training and 
resources to fully educate clients about critical aspects of 
PMTCT. Standard care in low-resource settings (often just 
one session of counselling with recently diagnosed HIV-pos-
itive pregnant women) is insufficient to provide the sup-
port a woman needs to seek appropriate care to ensure her 
health and that of her child. Issues such as the importance 
of disclosing HIV status, selecting and adhering to a safer 
method of infant feeding, practising family planning, and 
the importance of testing exposed infants for HIV, are often 
not adequately covered.
enhanCIng and suPPoRtIng PMtCt 
InteRVentIons
Successful efforts require that pregnant women receive ed-
ucation and support to understand the spectrum of PMTCT 
interventions. Comprehensive facility- and community-
based education and psychosocial support projects can in-
crease awareness and acceptance of these services. moth-
ers2mothers (m2m), a programme designed to improve 
PMTCT care and outcomes, has developed a unique service 
model, delivered in health care facilities and communities, 
that is cost-effective, easily replicable and scalable, and 
adaptable to serve diverse cultures and communities. m2m 
enhances and supports PMTCT programmes by employing 
HIV-positive mothers to join the health care team. These 
women, known as Mentor Mothers, provide comprehen-
sive peer education and psychosocial support to pregnant 
women and new mothers, aimed at increasing the uptake 
of PMTCT services to reduce HIV MTCT, empower women 
and destigmatise HIV/AIDS.
m2m’s Mentor Mothers are HIV-positive mothers who 
have recently completed the PMTCT process at the facilities 
where they work. m2m has developed a training curricu-
lum for Mentor Mothers that covers basic HIV/AIDS facts, 
PMTCT, disclosure, safer infant feeding, ARVs and HAART, 
safer sex, family planning, nutrition and other topics that 
help HIV-positive women to reduce transmission risk and 
improve their and their children’s health. Mentor Mothers 
also learn how to incorporate their own experiences into 
the educational and informational sessions that they give 
to m2m clients. As fellow mothers living with HIV/AIDS 
and trained as PMTCT experts, Mentor Mothers guide HIV-
positive pregnant women and new mothers through PMTCT 
care and assist with the post-delivery transition to ongoing 
HIV care and treatment programmes.
The m2m programme is designed to complement and en-
hance PMTCT services delivered in publicly funded clinics. 
Mentor Mothers are paid professional staff and essential 
members of a facility’s health care team whose sole focus 
is to educate and support pregnant women and new moth-
ers living with HIV/AIDS. Through daily educational health 
talks in clinic waiting rooms, Mentor Mothers encourage 
all pregnant women attending antenatal care (ANC) to 
undergo HIV testing. In facilities with delivery and other 
inpatient wards, Mentor Mothers visit pregnant and newly 
delivered mothers in the wards to support them in the HIV 
test process. Pregnant women who test positive for HIV are 
referred to m2m by clinic staff for one-on-one sessions 
and to attend support groups. These activities take place in 
the m2m-designated space within the clinic which offers 
women an inviting place where they can sit, talk, receive 
a meal and share the challenges they face as HIV-positive 
mothers.
The education that Mentor Mothers provide to HIV-posi-
tive pregnant women is aimed at assisting them to accept 
and access PMTCT services (Fig. 1). Mentors help pregnant 
The m2m logo on the front door at the Lesotho site.
Fig. 1. mothers2mothers client service timeline for enrolment and exit 
opportunities.
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women who have tested positive to understand their di-
agnosis by providing basic information on HIV and explain 
what steps a mother can take to reduce the risk of transmit-
ting the virus to her baby. As part of this education, Mentor 
Mothers stress the importance of CD4 count testing during 
pregnancy and starting HAART, if eligible. Pregnant women 
are educated about exclusive infant feeding options and 
assisted to formulate a plan for maintaining their chosen 
feeding method. Mentor Mothers also help pregnant wom-
en with disclosure to partners and family members.
After delivery, m2m continues to engage new moth-
ers with ongoing support and education on safer in-
fant feeding and other important post-delivery PMTCT 
actions. Mentor Mothers encourage women to bring 
babies back for HIV testing and to receive co-trimoxazole 
prophylaxis. Recognising that mothers are frequently lost 
to care after delivery, m2m assists women to enrol in HIV 
care and treatment programmes. Educational sessions are 
also given to new mothers on safer sex and family plan-
ning, as well as nutrition and how to live positively – all es-
sential for a mother’s health. By example and by providing 
emotional support, Mentor Mothers encourage HIV-posi-
tive women to adopt an attitude of hope and equip them 
with the information they need to lead healthier lives.
By the end of 2007, m2m had become an integral compo-
nent of PMTCT care at 155 facilities in South Africa and Le-
sotho, and employed more than 600 HIV-positive women. 
In that year, m2m had more than 300 000 patient encoun-
ters and is at present achieving more than 45 000 client 
contacts per month. The organisation has further expanded 
this year to provide services in Kenya, Rwanda and Zambia, 
and will open sites in Swaziland and Malawi before the year 
is out. The average cost of m2m services is approximately 
$US30 per patient.
An independent evaluation of m2m conducted by the Pop-
ulation Council’s Horizons Program in 2005 - 2006 found 
that m2m had a significant impact on critical components 
of PMTCT services.
13
 The cross-sectional study of self-re-
ported PMTCT knowledge, behaviours and attitudes among 
HIV-positive women at three facilities offering m2m serv-
ices in KwaZulu-Natal showed extensive coverage by the 
m2m programme, with more than 60% of women surveyed 
having heard of it. In addition, Mentor Mothers had sig-
nificant interactions (defined as two or more contacts) 
with nearly half of all the HIV-positive women attending 
antenatal care. Postpartum women at the study sites had 
on average six visits with m2m Mentor Mothers over the 
course of pregnancy and after delivery.
The study showed that women who received m2m services 
were significantly more likely to have: taken NVP and given 
their infants NVP for PMTCT; disclosed their HIV status to 
a partner or other person during their pregnancy; received 
and recalled the results of their CD4 test; and selected an 
	 	 	 No	m2m		 	 m2m		 	
	 	 	 participation	 	 participants
PMTCT	knowledge
   Knowledge that HIV+ mothers can infect baby during breastfeeding 72%   82%
Disclosure
   Disclosure to at least 1 person  85%   97%
†
Nevirapine	prophylaxis
   Provided with a drug for PMTCT  86%   95%
*
  
   Drug taken by woman  83%   93% 
†
 
   Baby given NVP within 3 days  78%   88%
*
Infant	feeding	practice
   Decided on feeding method before delivery  71%   87%
†
  
   Infant formula feeding, no breast milk  61%   78%
†
  
   Exclusive breastfeeding  15%    11%
†
   Exclusive method of feeding (total of above) 76%   89%
†
Family	planning
   Using contraception   58%   70%*
Referral	for	care
   Had a CD4 test during pregnancy  57%   79%
†
  
   Knew CD4 count   72%   88%
†
*Significant at p<0.05 significance level.
†
Significant at p<0.01 significance level.
taBle I. seleCted Results FRoM the hoRIZons eValuatIon: BIVaRIate analYsIs Results FoR  
PostPaRtuM WoMen (4 - 12 WeeKs aFteR delIVeRY)
suCCess so FaR
The m2m site at Lebohang clinic in Mpumalanga.
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exclusive infant feeding method while pregnant (Table I). 
Among postpartum women who received m2m services, 
89% chose an exclusive feeding method. In multivariate 
regression analysis, when controlling for other factors, 
postpartum women who received m2m services were 2.4 
times more likely to report exclusive formula feeding than 
non-participants (p<0.05).
13
 m2m participants were also 
significantly more likely than those who had not joined 
m2m groups to be using contraception at 4 - 12 weeks af-
ter delivery. m2m participants reported feeling less alone in 
the world and less overwhelmed by problems than women 
who did not attend the programme.
Preventing paediatric HIV infections and sustaining the 
health of mothers are critical components in stopping the 
spread of HIV and curtailing the epidemic’s destruction of 
lives, families and communities. Long-term care for moth-
ers infected with HIV is essential for sustaining their health 
and for the welfare of their children. Educating expectant 
and new mothers about PMTCT and HIV and empowering 
women through support services are key components of 
keeping mothers healthy, hopeful and alive for the raising 
of their children. The m2m programme enhances and im-
proves PMTCT services. Its ultimate goal is to improve the 
quality of life of those infected with, and affected by, HIV. 
The m2m model of peer education and support for HIV-
positive women throughout pregnancy and after delivery 
should be incorporated into all PMTCT programmes.
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m2m counselling provides education and emotional support 
for HIV-positive pregnant women and new mothers.
LOOKING FORWARD
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